AGGRENOX Safety Questions, AGGRENOX Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about AGGRENOX. Our extensive database of AGGRENOX adverse events and AGGRENOX warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about AGGRENOX

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




AGGRENOX Safety Reports

Total AGGRENOX reports: 131.
AGGRENOX FDA safety alerts: No.
Reported deaths: 11    Reported hospitalizations: 82.
Take AGGRENOX Side Effects Survey or Share Your AGGRENOX Story. AGGRENOX Usage.

Showing 1-75 of 131 Next >

Physician from GERMANY reported AGGRENOX problem on Aug 24, 2006. Male patient, weighting 191.8 lb, was diagnosed with cerebrovascular accident, cerebrovascular insufficiency and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: eye haemorrhage. AGGRENOX dosage: unknown. Patient recovered.

AGGRENOX problem was reported by a Physician from on Sept 05, 2006. Male patient, weighting 152.1 lb, was diagnosed with transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: angina pectoris. AGGRENOX dosage: unknown. Patient recovered.

Physician from UNITED STATES reported AGGRENOX problem on Sept 06, 2006. Male patient, 56 years of age, was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: endarterectomy, haemorrhagic stroke. AGGRENOX dosage: unknown. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from on Aug 31, 2006. Male patient, 76 years of age, was diagnosed with vascular shunt and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: arteriovenous graft thrombosis, haematocrit decreased, hyperkalaemia, post procedural haemorrhage. AGGRENOX dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported AGGRENOX problem on Sept 08, 2006. Male patient, 47 years of age, was diagnosed with vascular shunt and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: atrial flutter, bronchospasm, cardiac tamponade, chest pain, hypotension, pericardial effusion. AGGRENOX dosage: unknown. During the same period patient was treated with MINOXIDIL. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 08, 2006. Male patient, 48 years of age, was diagnosed with vascular shunt and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: cholangitis acute, hepatitis acute, post procedural haemorrhage. AGGRENOX dosage: unknown. During the same period patient was treated with AMBIEN, ASPIRIN, ATENOLOL, COLACE, EPOGEN, FOLIC ACID, HEPARIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported AGGRENOX problem on Jan 11, 2006. Male patient, weighting 172.0 lb, was diagnosed with cerebrovascular accident prophylaxis, reflux oesophagitis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: diabetic gastroparesis, reflux oesophagitis. AGGRENOX dosage: 200/75MG. During the same period patient was treated with MICARDIS, CLOPIDOGREL, REGLAN, PROTONIX. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Pharmacist from UNITED STATES on Oct 24, 2006. Male patient, 72 years of age, weighting 123.0 lb, was diagnosed with cerebrovascular accident and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. AGGRENOX dosage: unknown. During the same period patient was treated with ASPIRIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported AGGRENOX problem on Sept 06, 2006. Male patient, 57 years of age, was diagnosed with transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: cerebral haematoma, cerebral haemorrhage, endarterectomy, haemorrhagic stroke, hemiparesis, post procedural complication. AGGRENOX dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

AGGRENOX problem was reported by a Pharmacist from UNITED STATES on Oct 25, 2006. Male patient, 77 years of age, weighting 160.9 lb, was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: headache. AGGRENOX dosage: unknown. During the same period patient was treated with OMEPRAZOLE, FLUNISOLIDE, SIMVASTATIN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported AGGRENOX problem on Oct 30, 2006. Male patient, weighting 187.4 lb, was diagnosed with cerebrovascular accident prophylaxis, gastrooesophageal reflux disease, angina pectoris and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. AGGRENOX dosage: unknown. During the same period patient was treated with MICARDIS, CLOPIDOGREL, PERINDOPRIL ERBUMINE, ATENOLOL, SIMVASTATIN, ISOSORBIDE MONONITRATE, OMEPRAZOLE, GLYCERYL TRINITRATE SPRAY. Patient recovered.

AGGRENOX problem was reported by a Physician from UNITED STATES on Sept 06, 2006. Male patient, 57 years of age, was diagnosed with transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: cerebral haematoma, cerebral haemorrhage, endarterectomy, haemorrhagic stroke, hemiparesis, hemiplegia, lethargy, subdural hygroma. AGGRENOX dosage: unknown. During the same period patient was treated with NEXIUM, ALTACE, VYTORIN. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported AGGRENOX problem on Oct 30, 2006. Male patient, weighting 187.4 lb, was diagnosed with cerebrovascular accident prophylaxis, gastrooesophageal reflux disease, angina pectoris and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. AGGRENOX dosage: unknown. During the same period patient was treated with MICARDIS, CLOPIDOGREL, PERINDOPRIL ERBUMINE, ATENOLOL, SIMVASTATIN, ISOSORBIDE MONONITRATE, OMEPRAZOLE, GLYCERYL TRINITRATE SPRAY. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 27, 2006. Male patient, weighting 182.1 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: angina unstable. AGGRENOX dosage: unknown. During the same period patient was treated with MICARDIS, CLOPIDOGREL, ASPIRIN, DALTEPARIN, RAMIPRIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ISRAEL reported AGGRENOX problem on Nov 08, 2006. Male patient, weighting 211.6 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: erosive oesophagitis, oesophagitis ulcerative. AGGRENOX dosage: unknown. During the same period patient was treated with MICARDIS, CLOPIDOGREL. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from ISRAEL on Nov 08, 2006. Male patient, weighting 211.6 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: oesophagitis ulcerative. AGGRENOX dosage: unknown. During the same period patient was treated with MICARDIS, CLOPIDOGREL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported AGGRENOX problem on Sept 29, 2005. Female patient was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: headache. AGGRENOX dosage: SEE TEXT (SEE TEXT, 25MG/200MG (ONE CAPSULE BID)), PO. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2005. Male patient, 58 years of age, weighting 138.9 lb, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack, hiv infection and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: rash. AGGRENOX dosage: SEE TEXT (SEE TEXT, 25 MG/200 MG (2 CAPSULE A DAY)), PO. During the same period patient was treated with TMC, RITONAVIR, TENOFOVIR, GABAPENTIN, ATENOLOL, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported AGGRENOX problem on Feb 07, 2006. Male patient was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. AGGRENOX dosage: (SEE TEXT, 25 MG/200MG), PO. During the same period patient was treated with PLAVIX. Patient recovered.

AGGRENOX problem was reported by a Physician from UNITED STATES on Mar 14, 2006. Male patient was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: haemorrhage. AGGRENOX dosage: (SEE TEXT, 25 MG/200 MG) PO. Patient recovered.

Physician from UNITED STATES reported AGGRENOX problem on Sept 07, 2006. Female patient was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial. AGGRENOX dosage: SEE TEXT (SEE TEXT, 25 MG/200 MG, BID), PO. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Physician from UNITED STATES on Sept 07, 2006. Female patient was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial. AGGRENOX dosage: SEE TEXT (SEE TEXT, 25MG/200MG, BID), PO. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported AGGRENOX problem on July 13, 2006. Female patient, 68 years of age, weighting 135.9 lb, was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial. AGGRENOX dosage: SEE TEXT (SEE TEXT, 25 MG/200MG), PO. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Physician from UNITED STATES on July 12, 2006. Female patient was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, hypertension. AGGRENOX dosage: (SEE TEXT, 25MG/200MG). Patient recovered.

Physician from UNITED STATES reported AGGRENOX problem on July 12, 2006. Female patient was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, hypertension. AGGRENOX dosage: (SEE TEXT, 25MG/200MG). Patient recovered.

AGGRENOX problem was reported by a Physician from UNITED STATES on July 12, 2006. Female patient was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, hypertension. AGGRENOX dosage: (SEE TEXT, 25MG/200MG). Patient recovered.

Physician from UNITED STATES reported AGGRENOX problem on July 12, 2006. Female patient was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, hypertension. AGGRENOX dosage: (SEE TEXT, 25MG/200MG). Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from ISRAEL on Nov 08, 2006. Male patient, weighting 211.6 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: erosive oesophagitis, oesophagitis ulcerative. AGGRENOX dosage: unknown. During the same period patient was treated with MICARDIS, CLOPIDOGREL. Patient was hospitalized. Patient recovered.

Pharmacist from GERMANY reported AGGRENOX problem on Dec 05, 2006. Female patient, 80 years of age, was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. AGGRENOX dosage: unknown. During the same period patient was treated with NOVAMIN, TRAMADOL, IBUHEXAL, BELOC ZOK, ATORVASTATIN CALCIUM, PANTOZOL, DELIX. Patient recovered.

AGGRENOX problem was reported by a Physician from on Dec 11, 2006. Female patient, weighting 138.9 lb, was diagnosed with cerebrovascular accident, hypertension, diabetes mellitus, arteriosclerosis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: cerebral infarction. AGGRENOX dosage: unknown. During the same period patient was treated with ASPIRIN, BISOPROLOL FUMARATE, SIOFOR, SIMVAHEXAL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported AGGRENOX problem on Dec 21, 2006. Male patient, 81 years of age, weighting 279.1 lb, was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: headache. AGGRENOX dosage: unknown. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from ITALY on Aug 06, 2007. Male patient, weighting 172.0 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic. AGGRENOX dosage: unknown. During the same period patient was treated with MICARDIS, CLOPIDOGREL, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Physician from reported AGGRENOX problem on Aug 08, 2007. Female patient, weighting 163.1 lb, was diagnosed with ischaemic stroke, trigeminal neuralgia, hypothyroidism, goitre and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, dysphagia, dysphasia, sepsis. AGGRENOX dosage: unknown. During the same period patient was treated with PLAVIX, GABAPENTIN, LEVOTHYROXINE. Patient was hospitalized and became disabled. Patient recovered.

AGGRENOX problem was reported by a Physician from GERMANY on Aug 06, 2007. Female patient, weighting 141.1 lb, was diagnosed with thrombosis prophylaxis, oral candidiasis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: asthma. AGGRENOX dosage: unknown. During the same period patient was treated with BRONCHORETARD, OLMETEC, LACTULOSE NEDA, PHOSPHONORM, MAGNESIUM DIASPORAL, AMPHO MORONAL, LANZOPRAZOL, TORSEMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported AGGRENOX problem on Aug 02, 2007. Female patient, 55 years of age, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack, hypoaesthesia, extrasystoles and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling of body temperature change, headache, nausea, vomiting. AGGRENOX dosage: unknown. During the same period patient was treated with TOPROL. Patient recovered.

AGGRENOX problem was reported by a Pharmacist from GERMANY on Aug 15, 2007. Male patient, 73 years of age, was diagnosed with cerebrovascular accident and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: amnesia, disorientation. AGGRENOX dosage: unknown. During the same period patient was treated with TRENTAL, NOVONORM, ISDN RATIOPHARM, GODAMED, OMNIC OCAS, INDAPAMIDE, TENORMIN, BRONCHICUM TROPFEN. Patient recovered.

Physician from UNITED STATES reported AGGRENOX problem on Aug 07, 2007. Female patient, 82 years of age, weighting 130.1 lb, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: rash. AGGRENOX dosage: unknown. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2007. Female patient, 85 years of age, weighting 138.9 lb, was diagnosed with transient ischaemic attack, cerebrovascular accident prophylaxis, hypertension, gastrooesophageal reflux disease and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: groin pain, headache, loss of consciousness, muscle spasms, nausea, pain in extremity, pyrexia, rash macular. AGGRENOX dosage: 50MG/400MG. During the same period patient was treated with ZEGERID, DILTIAZEM, BENICAR, ASPIRIN, ATENOLOL, SKELAXIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported AGGRENOX problem on Aug 08, 2007. Female patient, 77 years of age, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: headache, night sweats. AGGRENOX dosage: unknown. During the same period patient was treated with PREVACID, SYNTHROID, WELLBUTRIN, COZAAR, LIPITOR. Patient recovered.

AGGRENOX problem was reported by a Physician from UNITED STATES on Aug 08, 2007. Female patient, 80 years of age, was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: purpura. AGGRENOX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported AGGRENOX problem on Aug 14, 2007. Female patient, 60 years of age, was diagnosed with transient ischaemic attack, diabetes mellitus and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: capillary disorder, gingival bleeding. AGGRENOX dosage: unknown. During the same period patient was treated with BYETTA. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2007. Female patient, 67 years of age, was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: dizziness, headache. AGGRENOX dosage: unknown. During the same period patient was treated with EVISTA, SYNTHROID, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported AGGRENOX problem on Aug 17, 2007. Female patient, 55 years of age, weighting 220.5 lb, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack, hypoaesthesia, extrasystoles and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling of body temperature change, headache, nausea, vomiting. AGGRENOX dosage: unknown. During the same period patient was treated with TOPROL. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2007. Male patient, weighting 220.5 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: renal failure chronic. AGGRENOX dosage: 400 / 50MG. During the same period patient was treated with MICARDIS, CLOPIDOGREL. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported AGGRENOX problem on Sept 04, 2007. Female patient, 57 years of age, weighting 165.0 lb, was diagnosed with cerebrovascular accident, prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: chills, dizziness, feeling cold, headache, hypoaesthesia facial, vomiting. AGGRENOX dosage: unknown. During the same period patient was treated with OTC VITAMINS. Patient recovered.

AGGRENOX problem was reported by a Physician from on Sept 05, 2007. Male patient, 77 years of age, weighting 189.6 lb, was diagnosed with cerebral hypoperfusion and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: headache, hypertension, vomiting. AGGRENOX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported AGGRENOX problem on Aug 31, 2007. Female patient, 67 years of age, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: dizziness, headache. AGGRENOX dosage: unknown. During the same period patient was treated with EVISTA, SYNTHROID, ASPIRIN, GLUCOSAMINE CHONDROITIN, CALCIUM D. Patient recovered.

AGGRENOX problem was reported by a Physician from UNITED STATES on Sept 06, 2007. Female patient, 58 years of age, was diagnosed with cerebrovascular accident prophylaxis and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, cerebrovascular accident, transient ischaemic attack. AGGRENOX dosage: unknown. During the same period patient was treated with PROZAC, NEURONTIN, SINGULAIR, LIPITOR, DIOVAN, ASPIRIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported AGGRENOX problem on Sept 13, 2007. Male patient, 82 years of age, weighting 183.0 lb, was diagnosed with hypertension, hydraemia, blood cholesterol increased and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: brain stem infarction, headache, lacrimation increased, monoplegia, paralysis, speech disorder. AGGRENOX dosage: 200MG DIPYRIDAMOL + 25 MG ASS. During the same period patient was treated with ENALAPRIL MALEATE, NITRENDIPIN, ASPIRIN, ANTICHOLESTEREMIC, HEPARIN. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Physician from on Sept 17, 2007. Female patient, 84 years of age, was diagnosed with cerebrovascular accident and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: intestinal infarction. AGGRENOX dosage: unknown. Patient died on 09/09/2007.

Consumer or non-health professional from UNITED STATES reported AGGRENOX problem on Sept 11, 2007. Female patient, 80 years of age, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack, pain in extremity and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: headache. AGGRENOX dosage: unknown. During the same period patient was treated with LYRICA. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Male patient, 78 years of age, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: urine colour abnormal. AGGRENOX dosage: unknown. During the same period patient was treated with LIPITOR. Patient recovered.

Consumer or non-health professional from reported AGGRENOX problem on Sept 13, 2007. Male patient, 82 years of age, weighting 183.0 lb, was diagnosed with hypertension, hydraemia, blood cholesterol increased and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: brain stem infarction, headache, lacrimation increased, monoplegia, paralysis, speech disorder. AGGRENOX dosage: 200MG DIPYRIDAMOL + 25 MG ASS. During the same period patient was treated with ENALAPRIL MALEATE, NITRENDIPIN, ASPIRIN, ANTICHOLESTEREMIC, HEPARIN. Patient was hospitalized. Patient recovered.

AGGRENOX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Male patient, 83 years of age, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: abdominal distension, nausea, vertigo. AGGRENOX dosage: unknown. During the same period patient was treated with CARDURA, ECOTRIN, TRIAMTERENE AND HYDROCHLOROTHIAZIDE. Patient recovered.

Physician from reported AGGRENOX problem on Sept 24, 2007. Female patient, weighting 121.3 lb, was diagnosed with cerebrovascular accident, hypertension, cardiac failure, renal failure and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: abdominal pain, intestinal infarction. AGGRENOX dosage: unknown. During the same period patient was treated with METOHEXAL, PHOSPHONORM, RAMIPRIL. Patient died on 09/09/2007.

AGGRENOX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Female patient, 80 years of age, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack, pain in extremity, neuropathy peripheral and was treated with AGGRENOX. After drug was administered, patient experienced the following problems/side effects: headache. AGGRENOX dosage: unknown. During the same period patient was treated with LYRICA, FOSAMAX. Patient recovered.

Showing 1-75 of 131 Next >

Ask Our Patient Community about AGGRENOX

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert